PatientView's
latest
Quarterlies

To read more about any of the Quarterlies, please click on its illustration. You will be taken to the website of the PatientView blog or on our prezi account

January 2013

The Corporate reputation of Pharma - the Patient Perspective 
Published January 14th 2013 

• A global survey, conducted mid-November to mid-December 2012, exploring the views of 600 international, national, and regional patient groups from 56 countries (72% from Europe) and differing specialties. 
  
• Patient group feedback on the corporate reputation of the pharma industry during 2012.
  
• Patient group feedback provides rankings of 29 leading pharma companies for six key indicators that influence corporate reputation: patient-centredness; patient information; patient safety; useful products; transparency; and integrity.
• Results for 2012 are compared with those of 2011.

October 2012

Benchmarking the Impact of the Patient Movement - a new tool
PART II
The effectiveness of patient groups
> 8  key indices
> Assessed according to 1,000 patient groups from around the world
>For 11 therapy areas

July 2012
Benchmarking the Impact of the Patient Movement - a new tool
PART I
Three key barometers
* The views of 1,000 patient groups from around the world
* The views of 20 senior healthcare professionals from around the world 
* The views of 30 senior healthcare industry executives from around the world
Patient groups in 10 countries/regions of the world benchmarked for effectiveness  
 

January 2012
The Corporate Reputation of Pharma -- the Patient Perspective
A global survey of 500 influential patient groups

July 2011
How can Industry Build Relationships with Patient Groups?
A global survey of 850 international, national and large regional patient groups

________________________________________________________________________________

Forthcoming PatientView Quarterlies

'Strategies  to improve patient-industry relations 
PatientView Quarterly
Scheduled for publication April 2013

_______________________________________________________________________________________________________